Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma

被引：0
|
作者：
Da Hyun Kang
Sung Soo Jung
Min-Kyung Yeo
Da Hye Lee
Geon Yoo
Sang Yeon Cho
In-Jae Oh
Ju-Ock Kim
Hee Sun Park
Chaeuk Chung
Jeong Eun Lee
机构：
[1] College of Medicine,Division of Pulmonology, Department of Internal Medicine
[2] Chungnam National University,Department of Pathology, College of Medicine
[3] Chungnam National University,Department of Internal Medicine
[4] Korea Institute of Toxicology,undefined
[5] Chungnam National University School of Medicine,undefined
[6] Chonnam National University Medical School,undefined
来源：
BMC Cancer | / 20卷
关键词：
Mig-6; EGFR-TKI; Lung adenocarcinoma; Chemotherapy resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] An Observational Study of Acquired EGFR T790M-Dependent Resistance to EGFR-TKI Treatment in Lung Adenocarcinoma Patients in Taiwan
    Wu, Shang-Gin
    Chiang, Chi-Lu
    Liu, Chien-Ying
    Wang, Chin-Chou
    Su, Po-Lan
    Hsia, Te-Chun
    Shih, Jin-Yuan
    Chang, Gee-Chen
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [22] Histological Transformation after Acquired Resistance to the Third-Generation EGFR-TKI in Patients with Advanced EGFR-Mutant Lung Adenocarcinoma
    Lee, Po-Hsin
    Huang, Yen-Hsiang
    Lin, Ho
    Hsu, Kuo-Hsuan
    Chen, Kun-Chieh
    Tseng, Jeng-Sen
    Chang, Gee-Chen
    Yang, Tsung-Ying
    MEDICINA-LITHUANIA, 2022, 58 (07):
  • [23] Concurrent use of anlotinib overcomes acquired resistance to EGFR-TKI in patients with advanced EGFR-mutant non-small cell lung cancer
    Zhang, Chen
    Cao, Honggang
    Cui, Yanan
    Jin, Shidai
    Gao, Wen
    Huang, Chenjun
    Guo, Renhua
    THORACIC CANCER, 2021, 12 (19) : 2574 - 2584
  • [24] Mig-6 overcomes gefitinib resistance by inhibiting EGFR/ERK pathway in non-small cell lung cancer cell lines
    Li, Zi-Xuan
    Qu, Lian-Yue
    Hi-Wen
    Zhong, Hong-Shan
    Xu, Ke
    Qiu, Xue-Shan
    Wang, En-Hua
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (10): : 7304 - 7311
  • [25] TFF3 drives Hippo dependent EGFR-TKI resistance in lung adenocarcinoma
    Zhang, Shuwei
    Tan, Yan Qin
    Zhang, Xi
    Basappa, Basappa
    Zhu, Tao
    Pandey, Vijay
    Lobie, Peter E.
    ONCOGENE, 2025, 44 (11) : 753 - 768
  • [26] EGFR/ MIG-6 SIGNALLING IN OSTEOARTHRITIS
    Bellini, M. R.
    Pest, M. A.
    Beier, F.
    OSTEOARTHRITIS AND CARTILAGE, 2017, 25 : S143 - S144
  • [27] Delivery of ATRA and Gefitinib by Polyphenylalanine Nanosystem to Overcome EGFR-TKI Resistance in Lung Adenocarcinoma
    Liu, S.
    Zhou, H.
    Xu, B.
    Deng, J.
    Zeng, F.
    Qiu, H.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S198 - S198
  • [28] EGFR/MIG-6 SIGNALLING IN OSTEOARTHRITIS
    Bellini, M. R.
    Pest, M. A.
    Beier, F.
    OSTEOARTHRITIS AND CARTILAGE, 2018, 26 : S79 - S80
  • [29] SLK Causes Resistance to EGFR-TKI in Lung Cancer
    Ashraf, K.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2371 - S2372
  • [30] SEVERAL RECEPTOR TYROSINE KINASE IS ACTIVATED BUT ORCHESTRATED BY EGFR IN EGFR-TKI ACQUIRED RESISTANT LUNG ADENOCARCINOMA CELLS WITH EGFR MUTATION
    Suda, Kenichi
    Mizuuchi, Hiroshi
    Sato, Katsuaki
    Takemoto, Toshiki
    Iwasaki, Takuya
    Minami, Kenji
    Yatabe, Yasushi
    Mitsudomi, Tetsuya
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S771 - S772
12345